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Summary 
The tumor necrosis factor (TNF-c~ or TNF) gene is activated by both lipopolysaccharide (LPS) 
and cycloheximide in RAW 264.7 macrophages, whereas neither stimulus activates the gene in 
3T3  fibroblasts. Moreover, the pattern of CG methylation within the TNF  gene is  readily 
distinguishable  in DNA derived from cells of these two types. These findings would suggest 
that the TNF gene has been rendered inaccessible to transcription  in the 3T3 cell environment. 
When RAW 264.7 cells are fused with 3T3 cells, an immortal pentaploid  hybrid results. In 
the hybrid cell, all three TNF genes contributed by the RAW 264.7 cell parent become highly 
methylated according to the pattern observed in the 3T3 cell parent.  Permanently transfected 
chloramphenicol acetyl transferase (CAT) reporter constructs, bearing 2.2 kb of upstream sequence 
(including the entire TNF promoter and 5'-untranslated region [UTR]) as well as 1.0 kb of 
downstream sequence (including the entire TNF 3'-UTR and termination sequence), are accessible 
in both RAW 264.7 cells and 3T3 cells, but are silenced in transition  from the RAW 264.7 
cell to the hybrid cell environment. Moreover, the endotoxin signaling pathway is abrogated, 
as assessed  by transient transfection of hybrid cells with LPS-responsive CAT repol ter constructs. 
It would therefore appear that the fusion of 3T3 cells and RAW 264.7 cells activates a system 
that silences the TNF gene, as well as the LPS signaling pathway. This system may operate to 
determine TNF gene accessibility and LPS responsiveness in the course of cell differentiation. 
The DNA sequences targeted within the TNF gene are included in the CAT reporter construct; 
therefore, the silencing element has been circumscribed to a region of DNA 3.2 kb in length. 
p revious work has revealed  that expression  of the TNF gene 
is regulated both at transcriptional  and at translational 
levels in macrophages (1). The duality of control mechanisms 
perhaps assures that induction at the protein level is of a very 
high order or, stated differently, that little or no TNF pro- 
tein is made by cells in the absence of an activating stimulus. 
However, additional regulatory mechanisms, chiefly of a 
suppressive character (2), must surely be set in place during 
cell differentiation. So much is evident from the fact that trans- 
fected copies of  TNF promoter are well utilized in most (and 
probably all) cells, whereas the TNF locus itself is absolutely 
silent (3); comparatively  few cell types are capable of expressing 
the TNF mRNA or protein (4-10).  Among cells that are 
capable of  expressing the TNF gene, the macrophage is unique, 
insofar as it is capable of secreting '~1,000 times more TNF 
in response to LPS (11-14) than any other cell type. One might 
therefore suppose that the TNF gene is highly accessible in 
macrophages, or that macrophages are endowed with factors 
that permit high-level expression of this gene. 
To examine the accessibility of the TNF gene in a type 
of cell that does not normally express TNF, and to analyze 
the suppressive mechanisms that maintain the gene in a per- 
manently inactive state, we investigated the behavior of the 
TNF gene in 3T3 cells. TNF is not normally synthesized 
by 3T3 cells, in response to LPS or any other known stimulus 
(our unpublished observations), and therefore, these cells may 
serve as a model system in which to study repression of the 
TNF gene. RAW 264.7 macrophages maintain the TNF gene 
in an accessible  form, and display an intact LPS signal trans- 
duction pathway (14-16). We sought to analyze differences 
between the RAW 264.7 and 3T3 phenotypes through studies 
of TNF gene structure, gene accessibility, and LPS signaling 
competence. Because we felt that 3T3 cells might lack any 
means of responding to LPS (e.g., might lack a receptor for 
LPS, or any number of proteins required for signal transduc- 
tion), a more direct means of stimulating the TNF gene was 
used in these cells. Cycloheximide was used to test accessi- 
bility of the TNF gene (and certain reporter genes), since 
protein synthesis inhibitors have been shown to suppress the 
biosynthesis of labile repressors that block TNF gene tran- 
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of endotoxin signal  transduction  pathways  (17). 
We sought to determine whether the mechanism respon- 
sible for suppression of LPS-induced TNF synthesis in 3T3 
cells was dominant or recessive, and whether it entailed inhi- 
bition at the level of the TNF gene, the LPS signal transduc- 
tion pathway,  or both. 
Materials  and Methods 
Cell Lines and Somatic CellHybrids.  RAW 264.7 and NIH 3T3 
cells were originally obtained from American Type Culture Col- 
lection (Rockville, MD), and passaged  in DMEM supplemented 
with  5%  FCS and 4%  penicillin/streptomycin solution (Gibco 
Laboratories,  Grand Island,  NY). Each of the cell lines was stably 
cotransfected with  pSV2neo and  the  CATTNF reporter gene,  a 
minigene construct in which transcription is driven by a full-length 
TNF promoter, and in which the CAT coding sequence is flanked 
by both the TNF untranslated regions (16). Each of the lines was 
also rendered puromycin resistant. In the case of RAW 264.7 cells, 
this was accomplished by growing the cells in increasing concen- 
trations of puromycin, beginning with a concentration of I #g/ml, 
and ultimately reaching a concentration of 50 #g/ml, which is le- 
thal to unacclimated NIH 3T3 cells. In the case of NIH 3T3 cells, 
resistance was achieved by transfecting  the cells with pSV2puw (18), 
and sdecting for growth in the presence of puromycin at a concen- 
tration of 10 #g/ml, which resulted in the death of nontransfected 
cells. NIH 3T3 cells were also transfected with pSV2neo alone. 
A somatic cell hybrid, in which the CATrnr construct was con- 
tributed by the RAW 264.7 cell genome, was produced by mixing 
the cells  at  a density of 106 each  in  six-well  plates  (diameter, 
3 cm). After attachment, cells were washed five times in serum- 
free DMEM,  and were then overlayed with polyethylene glycol 
(PEG), 1  1500  mol  wt  (American  Type  Culture  Collection), 
melted, and diluted 1:1 with DMEM.  The ceils were incubated 
with PEG for 2 min at 37~  They were then washed three times 
with serum-free DMEM, and then incubated for 24 h in DMEM 
supplemented  with  5%  FCS.  Selection  was  then  initiated  by 
growing the cells in the presence of both G418 (1 mg/ml) and 
puromycin (10 #g/ml) Several control cultures were initiated in par- 
allel with the experimental culture just described. These included 
cultures in which parental cells were plated in isolation from one 
another and treated with PEG as described above, and cultures in 
which isolated  parental cells, or mixtures of the two cell types, 
were plated but not exposed to PEG. All of the control cultures 
died in the process of selection.  However, after 15 d, numerous 
colonies were apparent in the experimental fusion cultures. 
The same procedure was followed to create hybrid cells that lacked 
the  CATrsr  reporter;  however,  the  parental lines  consisted  of 
RAW 264.7 cells that had been acclimated to growth in the pres- 
ence of puromycin, and 3T3 cells that had been transfected with 
pSV2neo. 
Cytogenetic analysis of the hybrid cell lines was carried out in 
the Department of Pathology Cytogenetics Laboratory, Univer- 
sity of Texas Southwestern Medical Center. 10 of 20 cells analyzed 
had between 98 and 101 chromosomes; the modal number was 100 
(4 of 20 cells analyzed). Therefore, hybrids were considered to be 
pentaploid (as expected, given their derivation from triploid [RAW 
264.7]  and diploid [NIH 3T3] parental lines). 
1  Abbreviations used in this paper: LAR,  locus activation region; PEG, 
polyethylene  glycol; TSE, tissue-specific  extinguisher; UTR, untranslated 
region. 
Transfection.  Permanently transfected RAW 264.7 cells and NIH 
3T3 cells used for all studies were produced previously (16). Tran- 
sient transfection of NIH 3T3 cells and RAW 264.7  x  NIH 3T3 
hybrid cells was carried out using calcium phosphate precipitates 
of cesium chloride-purified DNA as detailed  elsewhere (19). 
TNF Assay.  The L929 cytotoxicity assay was used to measure 
mouse TNF production by the cell lines used in these studies (20). 
CAT Assay.  The TLC procedure of Gorman (20a) was used 
to assay CAT activity. In all cases, 106 permanently transfected cells 
were lysed by freezing in 120 #1 of 0.25 M tris, pH 7.4, and after 
centrifugation, one-half of the supematant was used for CAT assay. 
In transient  transfection  studies, 106 cells were initially transfected, 
and the entire culture was treated with LPS or left untreated after 
48 h. Cells were lysed for CAT assay 64 h after initiation of trans- 
fection. 
RNA (Northern) Blot Analysis.  RNA was prepared as previously 
described (15). Samples were carefully quantitated both by mea- 
surement of OD at 260 nm, and by ethidium bromide staining 
after electrophoresis in agarose gels. Samples were diluted to con- 
tain precisely 15 gg of RNA per lane, and denatured in 100% for- 
mamide. 1 M glyoxal and bromophenol blue was added, and samples 
were heated to a temperature of 65~  for 5 min. They were then 
subjected to electrophoresis in 1.2% agarose, dissolved in Tris/ace- 
tate/EDTA buffer (21). Transfer to a nylon filter was accomplished 
electrophoretically, and the RNA was crosslinked  by ultraviolet 
irradiation using a Stratalinker apparatus (Stratagene, La Jolla, CA). 
The membrane was briefly immersed in a buffer containing 50% 
formamide, 1% SDS, and 5 x  SSC at 68"C. An antisense riboprobe 
hybridizing with CAT (0.8 kb) or TNF (1.1 kb) mRNA was added 
to identify the respective mRNA species (21). After overnight in- 
cubation at 68"C, the membrane was washed twice with 2 x  SSC 
containing 1.5% SDS at 72"C for 20 min per wash, and twice 
with 0.2x SSC containing 1% SDS, at the same temperature, and 
for the same period of time. Total RNA was visualized afterward 
by staining the membrane with methylene blue (21). 
Genomic DNA (Southern) Blot Analysis.  Genomic DNA was pre- 
pared as described elsewhere  (21). Digestion with restriction en- 
donucleases that were either sensitive to CG methylation or meth- 
ylation insensitive  was carried out under conditions appropriate 
for each enzyme. DraI was chosen as a methylation-insensitive en- 
zyme, and MspI and HpalI were chosen as enzymes that recognize 
the same sequence motif (CCGG), but that have different senti- 
tivity to methylation (only HpalI is inhibited by methylation). 30 
gg (when probing the TNF gene) or 10 gg (when probing the 
CAT reporter gene) of genomic DNA was applied  to each lane 
of an agarose gel and subjected to electrophoresis for a period of 
14 h, using a field strength of 2 V/cm. After ethidium bromide 
staining,  UV nicking, denaturation,  and capillary  transfer,  pre- 
hybridization and hybridization were carried out as elsewhere de- 
scribed  (21). 
Other Materials.  Enzymes for restriction analysis were obtained 
from Pharmacia Fine Chemicals (Piscataway, NJ). G418 was ob- 
tained from Gibco Laboratories (Grand Island,  NY). Puromycin 
and cycloheximide were obtained from Sigma Chemical Co. (St. 
Louis, MO). LPS (Escherichia  coli strain 0.127:B8) was obtained 
from Difco Laboratories (Detroit, MI). LPS and cyclobeximide were 
applied to cells at concentrations and for time intervals  stated in 
the figure legends. 
Results 
The TNF Gene Is Highly Met~lated and Genetically Inac- 
tive in 3T3 Cells.  To assess the degree of methylation of the 
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ation of  the TNF gene  in 3T3 cells, 
RAW 264.7 cells, and somatic cell 
hybrids. Cleavage, electrophoresis, 
and  blot  hybridization of DNA 
from each cell type was carried out 
as described  in Materials and Me- 
thods. Membrane was exposed to 
film without intensifying  screens  for 
48 h. (Left)  Cleavage  with methy- 
lation-sensitive enzymes. (Right) 
Cleavage with  the  methylation- 
insensitive enzyme DraI and with 
the differentially methylation-sen- 
sitive enzyme  pair HpalI and Mspl. 
TNF gene within 3T3 cells and within RAW 264.7 macro- 
phages, genomic DNA was obtained from cells of each type 
and  digested  to  completion  with  a  panel  of methylation- 
sensitive and -insensitive  restriction  endonucleases  (Fig.  1, 
lanes I  and 3 for each enzyme).  Obvious differences in the 
cleavage pattern were observed with each of the methylation- 
sensitive enzymes used. In general,  the TNF gene was less 
readily cleaved in 3T3 cells than in RAW 264.7 maerophages 
(although some exceptions to this trend were observed), and 
overall,  the density of methylated restriction  sites appeared 
higher in the former cell type. Very similar cleavage patterns 
were observed when 3T3 and RAW 264.7 cell DNA samples 
were restricted with DraI (top  arrow), and with MspI (bottom 
arrow).  The  former  enzyme recognizes  a  nonmethylatable 
target sequence, whereas the latter is not blocked by methyl- 
ation of its target sequence. RAW 264.7 cell DNA was iden- 
tically cleaved by MspI and by HpalI,  suggesting  that  no 
modification occurs at the sites  recognized by this enzyme 
pair.  On the other hand, a marked difference in the cleavage 
pattern was observed when 3T3 cell DNA was cut with HpalI, 
as opposed to MspI. This suggests modification of the CCGG 
motifs that  occur in  the 3T3 cell TNF gene. 
Not surprisingly,  the TNF gene could not be induced by 
LPS within 3T3 cells, nor by cycloheximide treatment.  This 
latter finding,  taken together  with  evidence that  the TNF 
gene is heavily methylated in 3T3  cells,  indicates  that  the 
gene has been inactivated,  i.e.,  is not accessible to the tran- 
scriptional apparatus.  On the other hand, both LPS and cy- 
cloheximide readily induced TNF gene expression in RAW 
264.7  cells  (Fig.  2). 
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A  CAT Reporter Gene Bearing TNF Regulatory Elements 
Is Expressed  in Response  to Cycloheximide  in Both 3T3 and RAW 
264.7 Cells; LPS Elicits a Response in RAW 264.7 Cells Only. 
To test the integrity of the LPS signaling pathway in each 
cell type, a CAT reporter gene,  transcriptionally  driven by 
the TNF promoter and containing the TNF 5'-untranslated 
region (UTK) and 3'-UTK, was introduced into both of the 
lines by cotransfection with pSV2neo, and stable transfectants 
were isolated by G418 selection (16). The accessibility of the 
reporter construct was assessed in each call line by treatment 
with cycloheximide. As shown in Fig. 3, lanes C, the CAT 
mKNA  was  readily  induced  by  this  procedure,  both  in 
RAW 264.7 ceils and in 3T3 ceils.  It should be noted that 
the reporter  gene copy number  is far higher  in  the RAW 
264.7 cell genome than in the 3T3 cell genome (not shown), 
hence the disparity between cycloheximide induction in the 
two cell lines. 
On the other hand,  while the reporter is dearly capable 
of responding to this type of activating stimulus, CAT mRNA 
is not produced within transfected 3T3 cells in response to 
LPS. Only RAW 264.7 ceils respond (Fig. 3, lanes L), indi- 
cating  that  in 3T3 ceUs, some aspect of the LPS signaling 
apparatus  is absent  or defective. 
Hybrids Produced  by Fusing 3T3 and RAW 264.7 Cells Fail 
to Express the TNF Gene when Exposed to LPS.  Since 3T3 
cells maintain their TNF genes in an inactive state,  they may 
be assumed to have failed to activate the locus,  or to have 
silenced it at some point in transit through development or 
immortalization.  We reasoned that  if a specific mechanism 
for TNF  gene inactivation  exists in 3T3  cells  in  an  active Figure  2.  RNA (Northern) blot analysis of the TNF 
message in RAW 264.7 and 3T3 cells. Cells were either 
not induced (O), or induced for 2 h using 1 #g/ml LPS 
(L),  or 100/~g/ml cycloheximide (C). 
form, it might be detected through cell hybridization experi- 
ments.  Accordingly, G418-resistant 3T3 cells were fused to 
puromycin-resistant  RAW 264.7 cells using polyethylene- 
glycol, and the culture was selected for growth in the pres- 
ence of both agents. 
When the hybrid cells were exposed to LPS, no TNF was 
produced (data not shown), suggesting that the TNF genes 
contributed by the RAW 264.7 cell parent were no longer 
accessible, that the LPS signaling pathway was inoperable, 
or both.  LPS could not induce accumulation  of the TNF 
mRNA within hybrid cells, and cycloheximide could induce 
the gene at only 2% the level seen in the RAW 264.7 cell 
parent (Fig. 4). Methylation of the TNF genes derived from 
Figure  3.  Induction of the CATTNF reporter  mRNA in RAW 264.7 
cells, 3T3 cells, and a somatic cell hybrid.  Treatment  of the cells with no 
inducer,  with LPS, or with cycloheximide is indicated  as in Fig.  2.  An 
expanded  version of the first three lanes is shown for clarity (the same 
RNA samples were rerun on a separate gel with wider spacing). 
Figure  4.  Accessibility  and LPS responsiveness  of the TNF gene in RAW 
264.7 cells, 3T3 cells, and somatic cell hybrids. RNA (Northern) blot de- 
tection of the TNF message in these cell types was carried out using cells 
that had been left unstimulated  (O), that were stimulated  with LPS (L), 
or that  were  stimulated  with cycloheximide  (C). 
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the 3T3 parental line, rather than to that of the RAW 264.7 
line (Fig. 1, lanes 2 and 3 for each enzyme). Only the NarI 
site (cleavable in RAW 264.7 DNA, but uncleavable in 3T3 
DNA) was retained in a partially cleavable state in DNA de- 
rived from hybrid cells. Therefore, it would seem that factors 
contributed by the 3T3 cell are capable of directing specific 
inactivation of the TNF locus. Moreover, 3T3 cells enforce 
the adoption of their own methylation pattern within the 
heterokaryon; the RAW 264.7 cell pattern is largely discarded. 
The CAT Reporter Gene Is Minimally Accessible when Tram- 
ferred  to a  Heterokaryon  through  Cell  Fusion, Adopts  a  New 
Methylation Pattern, and Does Not Respond to LPS.  Since  cy- 
cloheximide  could not induce normal levels ofTNF gene ex- 
pression in hybrid cells, it was assumed that the gene had, 
for the most part, been rendered inaccessible. To determine 
whether sequences within the TNF gene were recognized 
in this process, the CAT reporter was introduced into the 
hybrid cell milieu with the RAW 264.7 genome, whereupon 
its accessibility could be examined by cycloheximide induc- 
tion.  Cycloheximide inducibility  was  drastically  reduced 
(~l,000-fold) with respect to the level of induction observed 
in the parental line itsdf (Fig. 3). 
Since the reporter gene originating within RAW 264.7 
cells was presumably unaltered by cell fusion, either with re- 
spect to copy number or position in the genome, it must 
be inferred that factors contributed by 3T3 cells participate 
to radically suppress the accessibility of the reporter gene in 
the hybrid call environment. Indeed, at some point in their 
history,  3T3  cells dearly  suppressed  accessibility of the 
authentic TNF locus, and have maintained the gene in an 
inactive  state ever since (Figs. 2 and 4). 
DNA from RAW 264.7 cells and from hybrid ceUs  in which 
the reporter was contributed by the same RAW 264.7 cell 
parent was then reanalyzed to examine the methylation pat- 
tern of the reporter gene in each environment. As illustrated 
in Fig. 5, ceU fusion forces the adoption of a new methyl- 
ation pattern by a reporter gene resident within the RAW 
264.7 cell genome. All of the enzymes used yielded different 
patterns when applied to the two DNA samples, except the 
methylation-insensitive  enzymes DraI and MspI (which cut 
DNA derived from each cell type in an identical fashion). 
Notably, HpalI (which recognizes the same sequence motif 
as MspI, but which is methylation sensitive) cuts the RAW 
264.7 cell reporter far differently than it cuts the same gene 
obtained from hybrid cells. 
We then sought to assess the integrity of  the LPS signaling 
pathway in hybrid cells. When the reporter was introduced 
into hybrid calls by fusion, neither the reporter mRNA (Fig. 
3) nor the reporter protein (Fig. 6,  top) were inducible by 
LPS. Transient transfection studies (Fig. 6, bottom) were also 
carried out, since we reasoned that inactivation of the reporter 
might be time dependent, and might require integration or 
completion of the cell cycle. The 3'-UTR of the TNF gene 
is known to diminish expression of reporter constructs to 
which it is attached  (3, 23); and therefore, when transient 
transfection  studies  were performed, a reporter construct 
Figure  5.  Modification  of the CAT reporter  construct resident in the 
RAW 264.7 cell genome after fusion with 3T3 cells. Enzymes  used for 
cleavage of DNA, and cell line of origin, are indicated.  A probe for CAT 
coding sequence was used in hybridization  instead of a TNF probe (used 
in  Fig.  1).  (Left) Methylation-sensitive  enzymes  and  the methylation- 
insensitive enzyme DraI. (Right) Differentially  sensitive HpalI/Mspl en- 
zyme pair. 
Figure  6.  LPS  signaling  in 
RAW 264.7 cells and a somatic 
cell  hybrid.  (Tbp) The  CATTNr 
reporter construct was introduced 
into RAW 264.7 cells  as indicated, 
and  judged  to  be  accessible as 
shown in Fig. 3. The parental cells 
and their fusion product were then 
stimulated  with no inducer  (-), 
or with LPS for 16 h at a concen- 
tration of 1/~g/ml (+). Cells were 
then lysed, and CAT activity was 
measured as described in Materials 
and Methods.  (Bottom) Transient 
transfeetion  of RAW 264.7,  hy- 
brid, and 3T3 cells with a TNF 
promoter-CAT construct.  Cells 
were stimulated with LPS for 16 h 
at a concentration of 5 gg/ml (+), 
or left untreated  (-) before lysis 
and  assay of CAT activity. 
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CAT/hGH 3'  UTR)  was used instead of the CATTNF re- 
porter. This construct was induced 50-fold in pools of per- 
manently transfected RAW 264.7 cell clones (24),  and was 
strongly LPS responsive in transiently transfected RAW 264.7 
cells as well (Fig.  6, bottom). However, though highly ex- 
pressed, the construct was entirely noninducible by LPS in 
the hybrid cell line, as in 3T3 cells, effectively proving that 
these cell types lack an intact LPS signaling pathway. 
Di~tt&sion 
The TNF promoter is ubiquitously used when introduced 
into cells by transfection (3). As dictated by cell differentia- 
tion, however, only a limited subset of cells express the TNF 
gene. Two general mechanisms seem to assure suppression 
of TNF biosynthesis in cells that do not secrete the hormone. 
One of these is translational suppression, which is chiefly de- 
pendent upon sequences present within the TNF Y-UTR 
(3,  15, 22, 23, 25,  26).  The importance of this mechanism 
in vivo has been amply demonstrated by studies in which 
mutation of the TNF Y-UTR was shown, in transgenic mice, 
to eventuate an autoimmune arthritis (27). The other mech- 
anism entails inactivation of the TNF gene, so that the pro- 
moter is no longer capable of driving transcription. 
The TNF gene is expressed at a far higher level in macro- 
phages (14) than in cardiac myocytes (28), astrocytes (6), ker- 
atinocytes (7), or any of the other cell types in which TNF 
production has been reported. It may be presumed that, in 
these other cell types, the gene is not fully accessible as it 
is in macrophages. In certain cells, as in the 3T3 cells of the 
present study, the gene has been silenced altogether. 
The molecular basis of mammalian gene activation (or in- 
activation) is poorly understood in most instances. It has per- 
haps been best studied in the case of the 3-globin locus.  In 
this example, it is clear that far-upstream sequences comprising 
a dominant control region, or locus activation region (LAR), 
respond to erythroid-specific factors to permit activation of 
the 3-globin duster (29-31). A similar LAR may act to permit 
expression of the TNF gene, and may be most fully utilized 
in macrophages. The location of a LAR, if such exists,  is 
not known. In the present study, we focus upon the exis- 
tence of elements that suppress (rather than activate) expres- 
sion of the TNF locus. 
The RAW 264.7 cell TNF genes are permanently silenced 
after fusion with a 3T3 cell (which itself maintains its TNF 
genes in an inactive form). The RAW 264.7 cell TNF locus 
also adopts a pattern of methylation similar to that of the 
3T3 cell TNF locus when these two cell types are fused. Meth- 
ylation and inactivation of a CAT reporter construct bearing 
TNF promoter, 5'-UTR,  and Y-UTR sequences likewise 
occurs when this artificial gene is transferred from the RAW 
264.7 cell to a hybrid cell environment through fusion with 
a 3T3 cell. Of note, however, the reporter construct remains 
accessible when directly transfected into 3T3 cells.  It may 
therefore be concluded that cell fusion induces or reconsti- 
tutes a specific system for recognition of the macrophage TNF 
locus, leading to its extinction. While it might have been 
antidpated that  such a system would operate only during 
cell differentiation, or in the process of immortalization, cell 
fusion is evidently capable of activating it. 
The exact sequences recognized by the suppressive system 
expressed within the hybrid cell environment remain to be 
determined. In principle, they might reside anywhere within 
the TNF gene, or at locations remote from the gene. How- 
ever, it would appear that the TNF coding sequence and in- 
trons are not critical for recognition, nor are remote sequences, 
since the reporter construct is, like the TNF gene itself, largely 
inactivated after cell fusion. The sequences recognized in the 
inactivation process have thus been circumscribed to a region 
of DNA that encompasses the distal coding sequence and 
Y-UTR of the lymphotoxin gene, the TNF promoter/en- 
hancer region, the TNF 5'-UTR, and the TNF 3'-UTR (a 
total of 3.2 kb of DNA). 
Presumably, 3T3 cells also silence the expression of other 
genes required for a response to LPS (i.e.,  genes encoding 
proteins that transmit the LPS signal). As such, the response 
to LPS is abolished when macrophages are fused with 3T3 
cells. Moreover, while a CAT reporter gene remains transcrib- 
able in the hybrid cell environment after introduction by tran- 
sient transfection, it is not induced after challenge with LPS. 
Extinction of differentiated cell functions has been studied 
in hepatocellular carcinoma cells, wherein fusion with a fibro- 
blast cell line leads to a shutoff of tyrosine aminotransferase 
gene expression (32). Tissue-specific extinguishers (TSE) have, 
in this case, been linked to human chromosome 17 (TSE1) 
(33) and to mouse chromosome I (TSE2) (34) by cytogenetic 
analyses, and the TSE 1 product is thought to be identical 
to the Rloe subunit of protein kinase A  (35). 
It is well known that high levels of cAMP block LPS re- 
sponses  in macrophages. Therefore, dibutyryl cAMP (36), 
pentoxifylline (36),  amrinone (37),  and other phosphodies- 
terase inhibitors effectively  block LPS-induced TNF biosyn- 
thesis, acting at a transcriptional level (38). However, the effect 
of TSE1 gene overexpression would be to diminish the sensi- 
tivity of the protein kinase A pathway to increases in CAMP 
concentration. As such, it would seem improbable that the 
TSE1 locus contributes to suppression of the LPS response 
or,  for that  matter,  to TNF  gene extinction.  Preliminary 
studies, not reported with the data shown, tend to support 
this view, insofar as transfection of RAW 264.7 and hybrid 
cells using RIa mutant expression constructs (39, 40) or pro- 
tein kinase A  inhibitor  expression constructs (41)  has  no 
influence upon LPS-induced TNF gene expression. Moreover, 
in unstimulated hybrid cells, cAMP concentration differs little 
from that observed in RAW 264.7 cells (data not shown). 
Conceivably, the same developmental mechanism that as- 
sures silence of the TNF gene may direct inactivation of other 
genes required for the response to LPS. As such, they would 
exist as constituents of a common developmental unit. How- 
ever, such a relationship has yet to be established. 
Further studies may ultimately elucidate the target sequences 
required for developmental inactivation of the TNF locus. 
It may be anticipated that disruption of elements required 
1388  Extinction of the Tumor Necrosis  Factor Locus for proper tissue targeting of TNF gene expression might 
lead to aberrant development, or to diseases with inflamma- 
tory characteristics, particularly if combined with mutations 
of the TNF  Y-UTR. 
We are grateful to Drs. Stan McKnight and to Richard Maurer for their help in providing the ILia and 
PKI constructs, respectively. We are also indebted to Dr. Jeff Wiseman, who kindly agreed to assay cAMP 
levels in NIH 3T3 cells, RAW 264.7 cells, and the hybrid cells used in these studies. 
This work was funded, in part, by a grant from the American Cancer Society (CD-510), and by a National 
Institutes of Health grant (5-P01-DK-42582). 
Address correspondence to Bruce Beutler, the Howard Hughes Medical Institute and Department of In- 
ternal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Y5.210, 
Dallas,  TX 75235. 
Received for publication 30 September  1992 and in revised form 28 January  1993. 
References 
1.  Beutler, B., J. Han, V. Kruys, and B.P. Giroir. 1992. Coor- 
dinate regulation of TNF biosynthesis at the levels of tran- 
scription and translation. Patterns of TNF expression in vivo. 
In Tumor Necrosis Factors: The Molecules and Their Emerging 
Role in Medicine.  B. Beutler, editor. Raven Press, Ltd. New 
York.  561-574. 
2.  Goodbourn, S.  1990.  Negative regulation of transcriptional 
initiation in eukaryotes. Biochim. Biophys. Acta. 1032:53. 
3.  Kruys, V., K. Kemmer, A. Shakhov, V. Jongeneel, and B. Beu- 
tler.  1992. Constitutive activity of the TNF promoter is can- 
celed by the 3' untranslated region in non-macrophage cell lines: 
a transdominant factor overcomes this suppressive effect. Proc. 
Natl. Acad. Sci. USA.  89:673. 
4.  Sung, S.-S.J., L.K.L. Jung, J.A. Wakers, W. Chen, C.Y. Wang, 
and  S.M.  Fu.  1988.  Production  of tumor  necrosis  factor/ 
cachectin by human B cell lines and tonsillar B cells, j. Extx 
Med. 168:1539. 
5.  Ohno, I., Y. Tanno,  K. Yamauchi,  and T. Takishima.  1990. 
Production of tumour necrosis factor by mastocytoma P815 
cells. Immunology. 69:312. 
6.  Chung,  I.Y., and  E.N.  Benveniste.  1990.  Tumor  necrosis 
factor-c~ production by astrocytes:  Induction by lipopolysac- 
charide,  IFN-gamma,  and IL-1B. J. Immunol. 144:2999. 
7.  Kock, A., T. Schwarz, K. Kirnbauer, A. Urbanski, P. Perry, 
J.C.  Ansel,  and T.A. Luger.  1990. Human keratinocytes are 
a source for tumor necrosis factor c~: evidence  for synthesis 
and release upon stimulation with endotoxin or ultraviolet light. 
J. Extx Med. 172:1609. 
8.  Giroir, B.P., T. Brown, and B. Beutler. 1992. Constitutive syn- 
thesis of tumor necrosis factor in the thymus. Proc. Natl. Acad. 
Sci. USA.  89:4864. 
9.  Giroir, B.P., K. Peppel, M. Silva, and B. Beutler. 1992. The 
biosynthesis of tumor necrosis factor during pregnancy: studies 
with a CAT reporter transgene and TNF inhibitor. Eur. Cytokine 
Network. 3:533. 
10.  Rubin, B.Y., S.L. Anderson, S.A. Sullivan, B.D. Williamson, 
E.A. Carswell,  and L.J. Old.  1986.  Nonhematopoietic cells 
selected for resistance to tumor necrosis factor produce tumor 
necrosis  factor. J. Exp. Med. 164:1350. 
11.  Matthews, N. 1978. Tumour-necrosis factor from the rabbit. 
II. Production by monocytes. Br. J. Cancer. 38:310. 
12.  Matthews, N. 1981. Tumour-necrosis factor from the rabbit. 
V. Synthesis in vitro by mononuclear phagocytes from various 
tissues of normal and BCG-injected rabbits. Br.J. Canc~ 44:418. 
13.  Nedwin, G.E., L.P. Svedersky, T.S. Bringman, M.A. PaUadino, 
and D.V. Goeddel. 1985. Effect of interleukin 2, interferon- 
gamma, and mitogens on the production of tumor necrosis 
factors  alpha  and beta. J. Immunol. 135:2492. 
14.  Beutler, B., J. Mahoney, N. Le Trang, P. Pekala, and A. Cerami. 
1985. Purification of cachectin, a lipoprotein lipase-suppressing 
hormone secreted by endotoxin-induced RAW 264.7 cells. J. 
Exp. Med. 161:984. 
15.  Hart, J., T. Brown, and B. Beutler. 1990. Endotoxin-responsive 
sequences control cachectin/TNF biosynthesis at the transla- 
tional level, j. Exp. Med. 171:465. 
16.  Beutler,  B., and T. Brown. 1991. A CAT reporter construct 
allows ultrasensitive estimation of TNF synthesis, and suggests 
that the TNF gene has been silenced in non-macrophage cell 
lines. J.  Clin. Invest. 87:1336. 
17.  Collart, M.A., D. Berlin, J.D. Vassalli, S. DeKossodo, and P. 
Vassalli. 1986. Gamma interferon enhances macrophage tran- 
scription of the tumor necrosis factor/cachectin, interleukin 
1, and urokinase genes,  which are controlled by short-lived 
repressors, j. Exp. Med. 164:2113. 
18.  Vara, J.A.,  A. Portela, J. Ortin, and A. Jimenez. 1986. Ex- 
pression in mammalian cells of a gene from Streptomyces  alboniger 
conferring puromycin resistance.  Nucleic Acids Res. 14:4617. 
19.  Chen, C., and H. Okayama.  1987. High-efficiency transfor- 
mation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 
7:2745. 
20.  Cseh,  K., and B. Beutler.  1989. Alternative cleavage of the 
cachectin/TNF propeptide results in a larger,  inactive  form 
of secreted protein, j. Biol. Chem. 264:16256. 
20a.Gorman, C.M., L.F. Moffat, and B.H. Howard. 1982. Recom- 
binant genomes which express chloramphenicol acetyltrans- 
ferase in mammalian cells. Mol. Cell. Biol. 2:1044. 
21.  Sambrook, J., E.F. Fritsch, and T. Maniatis.  1989. Molecular 
Cloning: A Laboratory Manual. Cold Spring Harbor Labora- 
1389  Kruys et al. tory, Cold Spring Harbor, NY. 
22.  Han, J., and B. Beutler.  1990. The essential role of the UA- 
rich sequence in endotoxin-induced cachectin/TNF synthesis. 
Eur. Cytokine  Network.  1:71. 
23.  Kruys, V., M. Wathelet, P. Poupart, R. Contreras, W. Fiefs, 
J. Content, and G. Huez. 1987. The 3' untranslated region 
of the human interferon-beta mRNA has an inhibitory effect 
on translation. Proc. Natl. Acad. Sci. USA.  84:6030. 
24.  Han, J., G. Huez, and B. Beutler.  1991. Interactive effects of 
the TNF promoter and 3'-untranslated regions. J. Immunol. 
146:1843. 
25.  Kruys,  V.I.,  M.G.  Wathelet,  and  G.A.  Huez.  1988. Iden- 
tification of a translation inhibitory element (TIE) in the 3' 
untranslated region of the human interferon-beta mRNA. Gene 
(Amst.).  72:191. 
26.  Kruys, V., O. Marinx, G. Shaw, J. Deschamps, and G. Huez. 
1989. Translational blockade imposed by cytokine-derived UA- 
rich sequences.  Science (Wash. DC).  245:852. 
27.  Keffer, J., L. Probert, H. Cazlaris,  S. Georgopoulos, E. Kas- 
laris, D. Kioussis,  and G. Kollias.  1991. Transgenic  mice ex- 
pressing  human turnout necrosis factor: a predictive genetic 
model of arthritis. EMBO (Eur. Mol. Biol. Organ.) J.  10:4025. 
28.  Giroir, B.P., J.H. Johnson, T. Brown, G.L. Allen, and B. Beu- 
tler. 1992. The tissue distribution of TNF biosynthesis during 
endotoxemia. J.  Clin.  Invest. 90:693. 
29.  Talbot, D., P. Collis,  M. Antoniou, M.  Vidal,  F. Grosveld, 
and D.R. Greaves. 1989. A dominant control region from the 
human  beta-globin  locus  conferring  integration  site-inde- 
pendent gene expression.  Nature (Lond.). 338:352. 
30.  Grosveld, F., G.R Van Assendelft, D.R. Greaves, and G. Kollias. 
1987. Position-dependent high-level expression of the human 
beta-globin gene in transgenic mice.  Cell. 51:975. 
31.  van Assendelft,  G.B., O. Hanscombe, F. Grosveld, and D.R. 
Greaves. 1989. The fl-globin dominant control region activates 
homologous and heterologous promoters in a tissue-specific 
manner.  Cell. 56:969. 
32.  Killary, A.M., and R.E.K. Fournier. 1984. A genetic analysis 
of extinction: trans-dominant loci regulate expression of liver- 
specific traits in hepatoma hybrid cells. Cell. 38:523. 
33.  Leach, R..J., M.J. Thayer, A.J. Schafer, and R.E.K. Fournier. 
1989.  Physical  mapping  of human  chromosome  17  using 
fragment-containing microcell hybrids.  Genomics. 5:167. 
34.  Chin, A.C., and R.E.K. Fournier. 1989. Tse-2: a trans-dominant 
extinguisher of albumin gene expression in hepatoma hybrid 
cells. Mol.  Cell. Biol. 9:3736. 
35.  Boshart, M., F. Weih, M. Nichols, and G. Schutz. 1991. The 
tissue-specific extinguisher locus TSE1 encodes a regulatory 
subunit of cAMP-dependent protein kinase.  Cell. 66:849. 
36.  Strieter, R.M., D.G. Remick, P.A. Ward, R.N. Spengler, J.P. 
Lynch III, J. Larrick, and S.L. Kunkel. 1988. Cellular and mo- 
lecular regulation of tumor necrosis factor-alpha  production 
by pentoxifylline. Biochem. Biophy. Res. Commun.  155:1230. 
37.  Giroir, B.P., and B. Beutler. 1992. Effect ofamrinone on tumor 
necrosis  factor production in  endotoxic shock.  Circ. Shock. 
36:200. 
38.  Han, J., P. Thompson, and B. Beutler.  1990. Dexamethasone 
and pentoxifylline inhibit endotoxin-induced cachectin/tumor 
necrosis  factor synthesis  at separate  points in the signalling 
pathway. J. Exp.  Med.  172:391. 
39.  Clegg, C.H., L.A. Correll, G.G. Cadd, and G.S. McKnight. 
1987. Inhibition of intraceUular cAMP-dependent protein ki- 
nase using mutant genes of the regulatory type I subunit. J. 
Biol. Chem.  262:13111. 
40. J~ttela, M., P. Kuusela, and E. Saksela. 1988. Demonstration 
of tumor necrosis factor in human amniotic fluids and super- 
natants of placental  and decidual  tissues.  La/~ Invest. 58:48. 
41.  Day, R.N., J.A. Walder, and R.A. Maurer. 1989. A protein 
kinase inhibitor gene reduces both basal and multihormone- 
stimulated prolactin gene transcription.J. Biol. Chem. 264:431. 
1390  Extinction of the Tumor Necrosis Factor Locus 